SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-239867
Filing Date
2021-08-09
Accepted
2021-08-09 07:31:23
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d177205d10q.htm   iXBRL 10-Q 1346804
2 EX-3.1 d177205dex31.htm EX-3.1 49228
3 EX-10.1 d177205dex101.htm EX-10.1 18366
4 EX-31.1 d177205dex311.htm EX-31.1 6437
5 EX-31.2 d177205dex312.htm EX-31.2 6264
6 EX-32 d177205dex32.htm EX-32 4940
  Complete submission text file 0001193125-21-239867.txt   6731217

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20210630.xsd EX-101.SCH 43044
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20210630_cal.xml EX-101.CAL 36376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20210630_def.xml EX-101.DEF 265242
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20210630_lab.xml EX-101.LAB 407486
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20210630_pre.xml EX-101.PRE 374465
12 EXTRACTED XBRL INSTANCE DOCUMENT d177205d10q_htm.xml XML 1205788
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 211154635
SIC: 2834 Pharmaceutical Preparations